# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3881532 | B | Antagonist activity against integrin alpha9beta1 (unknown origin) expressed in SW480 cells assessed as inhibition of integrin alpha9-dependent cell adhesion to tenascin by binding saturation assay | Homo sapiens | 9 | ALA3881521 | cell-based format | Patent Bioactivity Data | |
2. | ALA3881533 | B | Inhibition of C-terminal human lgG1 heavy chain constant region tagged recombinant soluble VCAM-1 binding to integrin alpha4beta1 in human Jurkat cells incubated for 30 mins by FACS based 15/7 antibody assay | Homo sapiens | 9 | ALA3881521 | cell-based format | Patent Bioactivity Data | |
3. | ALA3881534 | B | Selectivity for integrin alpha9beta1 (unknown origin) expressed in SW480 cells over integrin alpha5beta1 (unknown origin) | Homo sapiens | 9 | ALA3881521 | cell-based format | Patent Bioactivity Data | |
4. | ALA3881535 | B | Selectivity for integrin alpha9beta1 (unknown origin) expressed in SW480 cells over integrin alpha4beta7 (unknown origin) | Homo sapiens | 9 | ALA3881521 | cell-based format | Patent Bioactivity Data | |
5. | ALA3881536 | B | Inhibition of integrin alphaL beta2 receptor (unknown origin) | Homo sapiens | 9 | ALA3881521 | protein complex format | Patent Bioactivity Data |